Diabetes drug class appears to reduce recurrent gout flares
New data suggests that the glucose-lowering drug class sodium-glucose cotransporter-2 (SGLT2) inhibitors appear to reduce the risk for recurrent gout flares – and to lessen
New data suggests that the glucose-lowering drug class sodium-glucose cotransporter-2 (SGLT2) inhibitors appear to reduce the risk for recurrent gout flares – and to lessen